Headache & Pain
News
Phase 3 Trial of Dioscorea japonica Extracts To Be Initiated for Treatment of Pain From Diabetic Neuropathy
Tuesday, January 08, 2019—The planned initiation of a phase 3 double-blind, placebo controlled, 12-week study of Dioscorea japonica extracts (NB-01; Neurobo, Boston, MA) for pain relief in pa…
2018 Drug and Device Approvals for Neurology
January 2019—HEADACHE & PAIN Noninvasive Vagus Nerve Stimulation (Gammacore; electroCore, Basking Ridge, NJ) Cleared: November 28, 2018 and January 29, 2018 Indications: adjun…
Hometown Highlights: CGRP-Related Treatments for Headache
With Stephen D. Silberstein, MD
January 2019— What Is Most Significant About These New Treatments? For the first time, we’ve developed a treatment for migraine based on what causes migraine. We had the concep…
Headache Horizons: Done by Hand
Peter McAllister, MD
January 2019—Chiropractics, the headache patient, and the lost art of touch.
Cognitive Complaints and Neuropsychologic Testing
Nabil Ali, MD; Kendra Corning, PsyD, HSPP; and Laura M. Clark, PhD, ABPP
January 2019—When should neuropsychologic tests be ordered and what questions should testing answer?
American Academy of Neurology Call for Uniformity in Brain Death Standards
Thursday, January 03, 2019—Noting that only 1 state, Nevada, has adopted legislation requiring use of medically accepted guidelines for determining brain death, the American Academy of Neurology (AAN) i…
New Drug Application Accepted for Combined Bupivacaine/Meloxicam for Post-Operative Pain
Wednesday, January 02, 2019—The Food and Drug Administration (FDA) has accepted a new drug application (NDA) for fixed-dose combined bupivacaine/meloxicam (HTX-011; Heron Therapeutics, San Diego, CA), an…
American Headache Society Releases Statement on Integrating New Treatments for Migraine Into Practice
Friday, December 21, 2018—To provide health care professionals with updated guidance on the use of novel preventive and acute treatments for migraine in adults, the American Headache Society (AHS) publ…
